Christopher Hanyoung Lieu MD

Oncology•Aurora, CO

Associate Professor, University of Colorado School of Medicine

Request Appointment

12605 E 16th AveAurora, CO 80045
Book by Phone+1(720) 706-2537

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
University of ColoradoResidency, Internal Medicine, 2004 - 2007
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2004

Certifications & Licensure

CO State Medical License 2007 - 2027
TX State Medical License 2008 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Start of enrollment: 2012 Jan 01
Completed
Phase 1
Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer Start of enrollment: 2013 Feb 12
Terminated
Phase 1, Phase 2
Metabiomics Colon Cancer Clinical Research Study Start of enrollment: 2019 Mar 01
Unknown status
Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer Start of enrollment: 2014 Aug 29
COMPLETED
PHASE1
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies Start of enrollment: 2015 Dec 01
Terminated
Phase 2
Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas Start of enrollment: 2018 Oct 10
RECRUITING
PHASE1
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors Start of enrollment: 2021 Apr 11
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Contact
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer Start of enrollment: 2022 Mar 21
RECRUITING
PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Oligometastatic pancreatic cancer: current state of management and emerging therapies.
Andrii Khomiak, Nicole B Balmaceda, Sumaya A Ghaffar, Christopher H Lieu, Marco Del Chiaro
The Oncologist. 2025-06-04
1 citations
Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer.
Jacob B Leary, Junxiao Hu, Alexis Leal, S Lindsey Davis, Sunnie Kim
JCO Oncology Practice. 2025-03-01
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01

Journal Articles

Association of Cancer Immunotherapy with Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis
Sharon Solomon, Christopher H Lieu, Ashvini Reddy, Leisha A Emens, S Lindsey Davis, Lingmin He, JAMA

Lectures

Addressing Survivorship in Cancer Care
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

Advanced Colon Cancer Patients Lived Twice as Long with a Pfizer Combo Therapy, Trial FindsMay 30th, 2025
'This Is Going to Lead to Overtreatment': What We Heard This WeekMay 25th, 2025
FDA Advisory: Daratumumab Wins for Smoldering Myeloma Glofitamab Loses for Early Line R/R Diffuse Large B-cell LymphomaMay 22nd, 2025
Join now to see all